Preparation method of chicken infectious bronchitis N-2-hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nano living vaccine
A technology of hydroxypropyl trimethyl ammonium chloride and carboxymethyl chitosan, which is applied in the field of preparation of chicken infectious bronchitis nanometer live vaccines, can solve the problem of poor solubility, weak solubility, and chitosan dissolution effect. It can achieve the effect of long release time, reducing the dosage, and improving the immunity of the body.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0019] Specific embodiment one: the preparation method of chicken infectious bronchitis N-2-hydroxypropyltrimethylammonium chloride chitosan / carboxymethyl chitosan nano live seedling of the present embodiment is realized according to the following experimental steps:
[0020] 1. Take 50-400 μl IBV H120 virus liquid and add sterile deionized water to make up to 2mL, and then add 5mL of N-2-hydroxypropyltrimethyl chloride after filtration sterilization with a concentration of 0.5-2.0mg / mL Ammonium chloride chitosan solution, then stirred for 5min under the condition of 300r / min with stirring speed under aseptic conditions at room temperature, to obtain mixed solution A;
[0021] 2. Stir the mixed solution A at room temperature and under sterile conditions at a speed of 900r / min to 1300r / min for 1min, then add 2mL of N, O-carboxymethyl base chitosan solution; then magnetically stirred for 20min to 50min under constant stirring speed to obtain mixed solution B;
[0022] 3. Centri...
specific Embodiment approach 2
[0028] Specific embodiment 2: The difference between this embodiment and specific embodiment 1 is that the method of filter sterilization described in step 1 and step 2 is: filter through a 0.22 μm bacterial filter in a sterile operating bench. Other steps and parameters are the same as those in the first embodiment.
specific Embodiment approach 3
[0029] Specific embodiment 3: The difference between this embodiment and specific embodiment 1 or 2 is that in step 1, 200 μl of virus liquid is taken and 2 mL of sterile deionized water is added to make up 2 mL, and then added to 5 mL of the filtered solution with a concentration of 1.0 mg / mL. N-2-hydroxypropyltrimethylammonium chloride chitosan solution after sterilization. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com